A patient with asthma uses a salbutamol inhaler (SABA) more than three times a week for symptom relief and experiences nocturnal symptoms twice a month. Their current maintenance therapy is beclometasone dipropionate (ICS) 100mcg BD via pMDI. According to the BTS/SIGN Asthma guidelines, what is the most appropriate next step in management?